Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-11T19:55:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-28T10:17:14.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T00:09:24.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-22T18:13:05.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T09:16:45.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T09:50:51.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.